IIT Kanpur researchers, led by Professor Arun K Shukla, used cryo-EM to uncover the molecular basis of the atypical immune ...

A new review was published in Volume 13 of Oncoscience on May 22, 2026, titled "Adaptor proteins regulating tumor-associated macrophage polarization during cancer progression." ...

Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization and SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a ...

Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization and SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical ...

IRI is a shared pathological process in myocardial infarction, ischaemic stroke, acute kidney injury, lung injury, and graft dysfunction after transplantation.

It is increasingly recognized that galactose-deficient IgA in the glomerulus activates the alternative complement system and drives IgA nephropathy, including in the tubules and interstitium, leading ...

Multiple sclerosis is especially destructive because of its tendency to worsen progressively. Instead of working through the immune system, Quantum BioPharma’s Lucid-MS acts directly on the myelin ...

Some of the smallest residents in an infant’s gut may be doing far more than anyone realized. Two linked studies published in Nature Communications suggest that fungi, long overshadowed by bacteria in ...

If you live with asthma, you may have wondered whether certain foods could be making your symptoms worse. While diet does not ...

Rather than targeting the immune system, Quantum BioPharma’s Lucid-MS targets the myelin sheath. The case for Lucid-MS is grounded in more than a decade of rigorous science. Quantum BioPharma's path ...